CUBE vs VRTX · P/E 25, rev $1.07B vs P/E 30, rev $12.00B
CubeSmart (CUBE) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the CUBE and VRTX stock pages for the full models.
Not investment advice.